Common Mental Health Disorders and Their Current Prescription Patterns in Saudi Arabia's Primary Healthcare Settings

被引:1
作者
Alsabhan, Jawza [1 ]
Alanazi, Ashwaq [2 ]
Alhajaji, Raghad [3 ,4 ]
Elbashir, Malaz [5 ]
Alzahrani, Faisal [6 ,7 ]
Alhajaji, Fatima [6 ]
Almehmadi, Mariah [7 ]
Alqorashi, Salihah [7 ]
Fairaq, Bashaier Ahmed [8 ]
Alhazmi, Fayza [9 ]
机构
[1] King Saud Univ, Clin Pharm, Riyadh, Saudi Arabia
[2] King Fahad Med City, Hlth Cluster 2, Riyadh, Saudi Arabia
[3] Minist Hlth, Dept Publ Hlth, Mecca, Saudi Arabia
[4] Alhajj Primary Hlth Care, Makkah Hlth Cluster, Primary Care Dept, Mecca, Saudi Arabia
[5] Minist Hlth, Publ Hlth Adm, Infect Dis Dept, Jeddah, Saudi Arabia
[6] Minist Hlth, Publ Hlth Adm, Sch Hlth Dept, Mecca, Saudi Arabia
[7] Umm Alqura Univ, Coll Med, Mecca, Saudi Arabia
[8] Makkah Hlth Cluster, Hlth Promot Adm, Mecca, Saudi Arabia
[9] Makkah Hlth Cluster, Family Med, Mecca, Saudi Arabia
关键词
anxiety; primary health care centers; ssri; mental health; depression; DEPRESSION; ANTIDEPRESSANTS; MEDICINE;
D O I
10.7759/cureus.65562
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The mental healthcare program is widely implemented in primary healthcare settings in Saudi Arabia. It consisted of early screening and management of mental health disorders associated with chronic health conditions. Family physicians are authorized to prescribe selective serotonin reuptake inhibitors (SSRIs) for early management of mental health disorders in primary healthcare centers (PHCs). The aim of the study is exploring the prevalence of various types of mental health disorders and to assess the prescribing pattern of SSRIs in PHCs. Materials and methods A cross-sectional study based on the data from electronic health records, telephone interviews, and prescriptions of individuals administered SSRIs at PHCs. Results Among 219 patients visiting PHCs, 67.6% were female participants. Forty-four percent of the patients were 20-30 years old and 61.2% of them received SSRI medications. The most prevalent chronic condition was diabetes (22.5%) followed by hypertension (20.5%) and asthma (6.4%). The most prevalent mental disorder was major depressive disorder (MDD; 78.1%), followed by anxiety disorder (7.3%), panic disorder (6.4%), and MDD with anxiety disorders (5.5%). Conclusion Implementing mental healthcare programs in PHCs is believed to promote population health. MDD was the predominant mental health disorder among patients visiting PHCs, and SSRIs were the most prescribed medications in this setting. This suggests that mental healthcare programs in PHCs are effective in improving mental health outcomes.
引用
收藏
页数:7
相关论文
共 20 条
[1]  
Abdelwahid HA, 2011, SAUDI MED J, V32, P948
[2]   Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan [J].
Afridi, Muhammad Iqbal ;
Dogar, Imtiaz Ahmad ;
Nizami, Asad T. ;
Aslam, Rubina ;
Mustafa, Ali Burhan ;
Muhammad, Sharib Syed ;
Maheshwary, Neeta .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
[3]   Prevalence and Predictors of Post-Stroke Depression and Anxiety During COVID-19 Pandemic [J].
Ahmed, Zakaria M. ;
Khalil, Mohamed F. ;
Kohail, Ahmed M. ;
Eldesouky, Islam F. ;
Elkady, Ahmed ;
Shuaib, Ashfaq .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2020, 29 (12)
[4]   Effectiveness of common antidepressants: a post market release study [J].
Alemi, Farrokh ;
Min, Hua ;
Yousefi, Melanie ;
Becker, Laura K. ;
Hane, Christopher A. ;
Nori, Vijay S. ;
Wojtusiak, Janusz .
ECLINICALMEDICINE, 2021, 41
[5]  
Aljabr QM, 2021, ANN MED HEALTH SCI R, V11, P185
[6]   An innovative 5-Step Patient Interview approach for integrating mental healthcare into primary care centre services: a validation study [J].
AlKhathami, Abdullah Dukhail .
GENERAL PSYCHIATRY, 2022, 35 (04)
[7]  
[Anonymous], 2023, Depressive Disorder
[8]  
[Anonymous], 2023, Clinical practice guidelines for the treatment of depression across three age cohorts
[9]  
Badescu S V, 2016, J Med Life, V9, P120
[10]   Effect of antidepressants use in pregnancy on foetus development and adverse effects in newborns [J].
Balkowiec-Iskra, Ewa ;
Mirowska-Guzel, Dagmara M. ;
Wielgos, Miroslaw .
GINEKOLOGIA POLSKA, 2017, 88 (01) :36-42